EconPapers    
Economics at your fingertips  
 

Can At-Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa?

Adrienne Lucas and Nicholas Wilson

American Journal of Health Economics, 2018, vol. 4, issue 3, 358-382

Abstract: The single largest item in the US foreign aid health budget is antiretroviral therapy (ART) for the treatment of HIV/AIDS. Many supply- and demand-side factors in sub-Saharan Africa could cause smaller than expected epidemiological effects of this at-scale drug provision. We provide what appears to be the first quasi-experimental evidence on the effect of at-scale drug provision in a poor country, using the phased rollout of ART in Zambia, a setting where approximately one in six adults are HIV positive. Combining anthropometric data from national household surveys and a spatially based triple-difference specification, we find that local ART introduction increased the weight of high HIV likelihood adult women. This finding from a clinically difficult setting suggests that the generalized challenges of scalability of ART for adult health in sub-Saharan Africa are surmountable.

Keywords: foreign aid; health; HIV/AIDS; PEPFAR; targeting; Zambia (search for similar items in EconPapers)
JEL-codes: H40 H51 I12 J13 O12 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://www.mitpressjournals.org/doi/pdf/10.1162/ajhe_a_00105 (application/pdf)
Access to PDF is restricted to subscribers.

Related works:
Journal Article: Can At-Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa? (2018) Downloads
Working Paper: Can at Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa? (2017) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:tpr:amjhec:v:4:y:2018:i:3:p:358-382

Access Statistics for this article

American Journal of Health Economics is currently edited by Thomas Buchmueller

More articles in American Journal of Health Economics from MIT Press
Bibliographic data for series maintained by The MIT Press ().

 
Page updated 2025-03-24
Handle: RePEc:tpr:amjhec:v:4:y:2018:i:3:p:358-382